- Home
- DNLI vs BHC Comparison
DNLI vs BHC Comparison
Compare DNLI & BHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNLI
- BHC
- Stock Information
- Founded
- DNLI 2013
- BHC N/A
- Country
- DNLI United States
- BHC Canada
- Employees
- DNLI N/A
- BHC N/A
- Industry
- DNLI Biotechnology: Biological Products (No Diagnostic Substances)
- BHC Biotechnology: Pharmaceutical Preparations
- Sector
- DNLI Health Care
- BHC Health Care
- Exchange
- DNLI Nasdaq
- BHC Nasdaq
- Market Cap
- DNLI 3.3B
- BHC 3.0B
- IPO Year
- DNLI 2017
- BHC N/A
- Fundamental
- Price
- DNLI $20.84
- BHC $7.95
- Analyst Decision
- DNLI Strong Buy
- BHC Hold
- Analyst Count
- DNLI 11
- BHC 4
- Target Price
- DNLI $40.40
- BHC $7.25
- AVG Volume (30 Days)
- DNLI 867.7K
- BHC 1.3M
- Earning Date
- DNLI 02-25-2025
- BHC 02-20-2025
- Dividend Yield
- DNLI N/A
- BHC N/A
- EPS Growth
- DNLI N/A
- BHC N/A
- EPS
- DNLI N/A
- BHC N/A
- Revenue
- DNLI N/A
- BHC $9,474,000,000.00
- Revenue This Year
- DNLI N/A
- BHC $10.68
- Revenue Next Year
- DNLI $420.35
- BHC $3.66
- P/E Ratio
- DNLI N/A
- BHC N/A
- Revenue Growth
- DNLI 204.74
- BHC 10.91
- 52 Week Low
- DNLI $14.56
- BHC $3.96
- 52 Week High
- DNLI $33.33
- BHC $11.46
- Technical
- Relative Strength Index (RSI)
- DNLI 35.14
- BHC 51.59
- Support Level
- DNLI $19.93
- BHC $7.48
- Resistance Level
- DNLI $21.64
- BHC $7.77
- Average True Range (ATR)
- DNLI 0.96
- BHC 0.25
- MACD
- DNLI -0.06
- BHC 0.06
- Stochastic Oscillator
- DNLI 21.56
- BHC 65.08
About DNLI Denali Therapeutics Inc.
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.
About BHC Bausch Health Companies Inc.
Bausch Health Companies Inc is a global specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.